Vascular angiotensin II actions mediated by angiotensin II type 2 receptors

Current Hypertension Reports

Volumn 6, Issue 2, 2004, Pages 117-123

  Hannan, Ruth E ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; CANDESARTAN; CANDESARTAN HEXETIL; CYCLIC GMP; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; VALSARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST;

BLOOD VESSEL FUNCTION; DRUG EFFICACY; DRUG MECHANISM; HORMONE ACTION; HYPERTENSION; NONHUMAN; PHARMACODYNAMICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 4644262822     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0086-5     Document Type: Review

References (65)

1. De Gasparo M, Catt KJ, Inagami I, et al.: International Union of Pharmacology. XXIII. The Angiotensin II Receptors. Pharmacol Rev 2000, 52:415-472.
2. Carey RM, Jin XH, Siragy HM: Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens 2001, 14:98S-102S.
3. Widdop RE, Jones ES, Hannan RE, Gaspari TA: Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 2003, 140:809-824.
4. Kaschina E, Unger T: Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003, 12: 0-88.
5. Arima S, Endo Y, Yaoita H, et al.: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997, 100:2816-2823.
6. Endo Y, Arima S, Yaoita H, et al.: Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole. Kidney Int Suppl 1997, 63:S205-S207.
7. Dimitropoulou C, White RE, Fuchs L, et al.: Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension 2001, 37:301-307.
8. Katada J, Majima M: AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 2002, 136:484-491.
9. Matrougui K, Loufrani L, Heymes C, et al.: Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999, 34:659-665.
10. Widdop RE, Matrougui K, Levy BI, Henrion D: AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002, 40:516-520.
11. Henrion D, Kubis N, Levy BI: Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 2001, 38:1150-1157.
12. Touyz RM, Endemann D, He G, et al.: Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999, 33:366-372.
13. Burrell JH, Lumbers ER: Angiotensin receptor subtypes in the uterine artery during ovine pregnancy. Eur J Pharmacol 1997, 330:257-267.
14. Nora EH, Munzenmaier DH, Hansen-Smith FM, et al.: Localization of the Ang II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol 1998, 275:H1395-H1403.
15. Akishita M, Horiuchi M, Yamada H, et al.: Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2000, 2:13-20.
16. Wu L, Iwai M, Nakagami H, et al.: Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 2002, 22:49-54.
17. Chang RS, Lotti VJ: Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 1991, 49:1485-1490.
18. Viswanathan M, Tsutsumi K, Correa FM, Saavedra JM: Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991, 179: 361-1367.
19. Zhuo J, Dean R, MacGregor D, et al.: Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol Suppl 1996, 3: 147-S154.
20. Hannan RE, Davis EA, Widdop RE: Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Brit J Pharmacol 2003, 140:987-995.
21. Siragy HM, Carey RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′ 5′ -monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996, 97:1978-1982.
22. Siragy HM, Carey RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997, 100:264-269.
23. Siragy HM, Carey RM: Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 1999, 33:1237-1242.
24. Gohlke P, Pees C, Unger T: AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998, 31:349-355.
25. Tsutsumi Y, Matsubara H, Masaki H, et al.: Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999, 104:925-935.
26. Abadir PM, Carey RM, Siragy HM: Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003, 42:600-604.
27. Li XC, Widdop RE: AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol 2003, In press.
28. Munzenmaier DH, Greene AS: Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996, 27:760-765.
29. Tea BS, Der Sarkissian S, Touyz RM, et al.: Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension 2000, 35:1069-1073.
30. Barber MN, Sampey DB, Widdop RE: AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 1999, 34:1112-1116.
31. Carey RM, Howell NL, Jin XH, Siragy HM: Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001, 38:1272-1277.
32. Schuijt MP, Basdew M, van Veghel R, et al.: AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am J Physiol 2001, 281:H2590-H2596.
33. Lambers DS, Greenberg SG, Clark KE: Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep. Am J Physiol 2000, 278:H353-H359.
34. Bautista R, Sanchez A, Hernandez J, et al.: Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension 2001, 38:669-673.
35. Li XC, Widdop RE: Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats. Clin Sci 1996, 91: 47-154.
36. Phoon S, Howes LG: Role of angiotensin type 2 receptors in human forearm vascular responses of normal volunteers. Clin Exp Pharmacol Physiol 2001, 28:734-736.
37. Phoon S, Howes LG: Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)-receptors. J Renin Angiotensin Aldosterone Syst 2002, 3:36-39.
38. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U: The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001, 276:39721-39726.
39. Jin XQ, Fukuda N, Su JZ, et al.: Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 2002, 39: 021-1027.
40. Su JZ, Fukuda N, Jin XQ et al.: Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR. Hypertension 2002, 40:853-858.
41. Duke LM, Eppel GA, Widdop RE, Evans RG: Disparate roles of AT2 receptors in the renal cortical and medullary circulations of anesthetized rabbits. Hypertension 2003, 42:200-205.
42. Paull JR, Li XC, Sampey DB, Widdop RE: Pharmacodynamic contribution to the vasodilator effect of chronic AT(1) receptor blockade in SHR. Hypertension 2001, 37:91-98.
43. Senbonmatsu T, Ichihara S, Price E Jr, et al.: Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000, 106:R25-R29.
44. Akishita M, Iwai M, Wu L, et al.: Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 2000, 102:1684-1689.
45. Kurisu S, Ozono R, Oshima T, et al.: Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003, 41:99-107.
46. Janiak P, Pillon A, Prost JF, Vilaine JP: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992, 20:737-745.
47. Stoll M, Steckelings UM, Paul M, et al.: The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995, 95: 51-657.
48. Nakajima M, Hutchinson HG, Fujinaga M, et al.: The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995, 92:10663-10667.
49. Ohkubo N, Matsubara H, Nozawa Y, et al.: Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997, 96:3954-3962.
50. Tsutsumi Y, Matsubara H, Ohkubo N, et al.: Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998, 83:1035-1046.
51. Siragy HM, de Gasparo M, Carey RM: Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 2000, 35:1074-1077.
52. Liu YH, Yang XP, Sharov VG, et al.: Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997, 99: 926-1935.
53. Varagic J, Susic D, Frohlich ED: Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors. Hypertension 2001, 37:1399-1403.
54. Wu L, Iwai M, Nakagami H, et al.: Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001, 104:2716-2721.
55. Xu J, Carretero OA, Liu YH: Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension 2002, 40:244-250.
56. Opie LH, Sack MN: Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes. Circ Res 2001, 88:654-658.
57. Siragy HM, El-Kersh MA, De Gasparo M, et al.: Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. J Hypertens 2002, 20:1157-1163.
58. Santos RA, Campagnole-Santos MJ, Andrade SP: Angiotensin-(1-7): an update. Regul Pept 2000, 91:45-62.
59. Santos RA, Simoes e Silva AC, Maric C, et al.: Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003, 100: 258-8263.
60. Donoghue M, Hsieh F, Baronas E, et al.: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-E9.
61. Tipnis SR, Hooper NM, Hyde R, et al.: A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275:33238-33243.
62. Oudit GY, Crackower MA, Backx PH, Penninger JM: The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 2003, 13:93-101.
63. Carey RM, Siragy HM: Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003, 24:261-271.
64. Brosnihan KB, Neves LA, Joyner J, et al.: Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 2003, 42:749-753.
65. Loot AE, Roks AJ, Henning RH, et al.: Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002, 105: 548-1550.